TG Therapeutics | TGTX - Equity Capital And Reserves

Stock Price
30.69
Daily Change
-0.22 -0.70%
Monthly
1.24%
Yearly
1.98%
Q1 Forecast
28.61

TG Therapeutics reported $607.22M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Amgen USD 8.66B 961M Dec/2025
Ardelyx USD 154.28M 14.75M Sep/2025
Arrowhead Research USD 568.42M 102.37M Dec/2025
Bayer EUR 29.7B 799M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
J&J USD 78.47B 0 Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novavax USD -156.67M 194.3M Sep/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025
Verastem USD -32.43M 3.54M Mar/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025